Brain And Neuroimaging Devices Market
Brain and Neuroimaging Devices Market Forecasts to 2030 - Global Analysis By Imaging Type (Computed Tomography, Functional Magnetic Resonance Imaging, Positron Emission Tomography, Electroencephalography, Near Infrared Spectroscopy, Magneto encephalography, Intracranial Pressure Monitors, Cerebral Oximeters, Sleep Monitoring Devices, Electromyography Devices and Other Imaging Types ), Procedure (Invasive and Non-Invasive ), Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $22.4 BN |
|
Projected Year Value (2030) |
US $36.2 BN |
|
CAGR (2023 - 2030) |
7.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Brain and Neuroimaging Devices Market is accounted for $22.4 billion in 2023 and is expected to reach $36.2 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. The area of medical imaging known as neuroimaging focuses on the brain. Neuroimaging investigates how the brain functions in addition to identifying diseases and evaluating brain health. Neuroscientists can view the interior of the living brain using brain imaging devices.
According to the National Institute of Health, funding for neurodegenerative diseases was US$ 4,021 million in 2020.
Market Dynamics:
Driver:
Technology advancements
Technology advancements have increased the functionality and effectiveness of brain and neuroimaging device. The ability to investigate brain anatomy and function, for instance, has improved with the introduction of high-resolution imaging techniques like functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI). Additionally, as a result of technological advancements, the market is still growing since they make it possible for scans to be completed more quickly and with more patient comfort.
Restraint:
High cost of imaging equipment
The market for brain and neuroimaging technologies is predicted to suffer from the high cost of imaging equipment. High-end equipment is needed for brain-computer interface research in cognitive psychology and neurology, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and electroencephalography (EEG). However, these are expensive devices that not all hospitals and laboratories, particularly in developing nations, can afford. Therefore, the high cost of imaging systems, which limits the purchasing power of hospitals and diagnostic labs, is a barrier to the market for brain and neuroimaging devices.
Opportunity:
Personalized medicine and precision imaging
The objective of personalised medicine is to modify medical care in accordance with a patient's particular traits, including their particular brain structure and function. Neuroimaging technology can be quite useful in delivering individualised information for better treatment planning and neurological condition monitoring. Furthermore, in order to find patient-specific biomarkers and improve treatment outcomes, precision imaging approaches, including functional connectivity mapping and multimodal imaging integration, are being developed, which expands the market.
Threat:
Regulatory challenges
The market for brain and neuroimaging devices is subject to strict rules and authorization from regulatory agencies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Additionally, it might take time and money to obtain regulatory clearance or approval for new imaging technologies or devices. Companies in this area face difficulties adhering to evolving regulatory norms and criteria. These regulatory challenges hinder market growth.
Covid-19 Impact
The COVID-19 epidemic has had a wide range of effects on the market and the field of neuroimaging devices. The use of neuroimaging tools like MRI and CT scans in clinical settings increased as medical practitioners sought to comprehend exactly the virus affected the brain and the associated neurological symptoms. The demand for these gadgets and associated technologies increased as a result. The epidemic delayed the production and distribution of medical equipment, especially neuroimaging devices, and interrupted supply networks.
The ambulatory surgical centers segment is expected to be the largest during the forecast period
The ambulatory surgical centers segment is estimated to hold the largest share. In the market for brain and neuroimaging devices, the Ambulatory Surgical Centres (ASCs) segment is particularly important for the diagnosis and management of neurological diseases. These facilities frequently act as outpatient settings for a variety of medical interventions, such as neurosurgery and interventional radiological procedures, where neuroimaging technologies are crucial instruments. Neuroimaging equipment will continue to be crucial to the diagnostic and therapeutic pathways within ASCs as healthcare systems prioritise outpatient care and minimally invasive procedures.
The cerebral oximeters segment is expected to have the highest CAGR during the forecast period
The cerebral oximeters segment is anticipated to have lucrative growth during the forecast period. The Cerebral Oximeters, which specialises in measuring and evaluating cerebral oxygenation levels, is an essential part of the brain and neuroimaging devices industry. These tools, including near-infrared spectroscopy (NIRS) systems, are essential for non-invasively detecting the oxygen saturation levels in the brain's tissues and delivering significant information for evaluating cerebral health. In a variety of medical settings, such as operating rooms, neonatal care units, and research labs, these devices are increasingly used because they provide insightful information on brain health.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of neurological disorders. With a vast network of hospitals, clinics, and research facilities, North America has one of the most sophisticated healthcare infrastructures in the world. This infrastructure makes it easier to acquire and use neuroimaging technology for both research and clinical diagnosis. Numerous neurological injuries, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and other conditions are relatively common in this region.
Region with highest CAGR:
Europe is expected to witness profitable growth over the projection period. Europe is characterised by a strong healthcare system, cutting-edge medical technology, and a rising interest in neurological illnesses. A network of contemporary hospitals, clinics, and research facilities is part of Europe's established and extensive healthcare infrastructure. This infrastructure encourages the adoption and use of neuroimaging technology for clinical diagnosis and academic study. For early diagnosis, disease monitoring, and research, this high disease prevalence increases the need for improved neuroimaging technologies. Neuroimaging methods are more widely available to patients and medical professionals in many European nations thanks to favourable payment regulations.
Key players in the market
Some of the key players in the Brain and Neuroimaging Devices Market include Canon, Hitachi Medical Systems, General Electric Company, Philips, Varian Medical Systems, Siemens, Toshiba Medical Systems, NeuroSoft, Sanrad Medical Systems Pvt. Ltd, Esaote SpA, Medtronic Plc, Elekta AB, Natus Medical Incorporated, Magstim Company Ltd., Compumedics Limited and Brainlab AG.
Key Developments:
In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure.
In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon may participate in clinical and technical research programs, product evaluation projects, and consultations with Varian under this agreement to provide clinical expertise and industry perspectives throughout product development.
Imaging Types Covered:
• Computed Tomography
• Functional Magnetic Resonance Imaging
• Positron Emission Tomography
• Electroencephalography
• Near Infrared Spectroscopy
• Magneto encephalography
• Intracranial Pressure Monitors
• Cerebral Oximeters
• Sleep Monitoring Devices
• Electromyography Devices
• Other Imaging Types
Procedures Covered:
• Invasive
• Non-Invasive
Applications Covered:
• Traumatic Brain Injury
• Dementia
• Parkinson’s Disease
• Sleep Disorders
• Epilepsy
• Huntington's Disease
• Headache Disorders
• Other Applications
End Users Covered:
• Ambulatory Surgical Centers
• Diagnostic Centers
• Hospitals
• Clinics
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Brain and Neuroimaging Devices Market, By Imaging Type
5.1 Introduction
5.2 Computed Tomography
5.3 Functional Magnetic Resonance Imaging
5.4 Positron Emission Tomography
5.5 Electroencephalography
5.6 Near Infrared Spectroscopy
5.7 Magnetoencephalography
5.8 Intracranial Pressure Monitors
5.9 Cerebral Oximeters
5.10 Sleep Monitoring Devices
5.11 Electromyography Devices
5.12 Other Imaging Types
6 Global Brain and Neuroimaging Devices Market, By Procedure
6.1 Introduction
6.2 Invasive
6.3 Non-Invasive
7 Global Brain and Neuroimaging Devices Market, By Application
7.1 Introduction
7.2 Traumatic Brain Injury
7.3 Dementia
7.4 Parkinson’s Disease
7.5 Sleep Disorders
7.6 Epilepsy
7.7 Huntington's Disease
7.8 Headache Disorders
7.9 Other Applications
8 Global Brain and Neuroimaging Devices Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Diagnostic Centers
8.4 Hospitals
8.5 Clinics
9 Global Brain and Neuroimaging Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Canon
11.2 Hitachi Medical Systems
11.3 General Electric Company
11.4 Philips
11.5 Varian Medical Systems
11.6 Siemens
11.7 Toshiba Medical Systems
11.8 NeuroSoft
11.9 Sanrad Medical Systems Pvt. Ltd
11.10 Esaote SpA
11.11 Medtronic Plc
11.12 Elekta AB
11.13 Natus Medical Incorporated
11.14 Magstim Company Ltd.
11.15 Compumedics Limited
11.16 Brainlab AG
List of Tables
1 Global Brain and Neuroimaging Devices Market Outlook, By Region (2021-2030) ($MN)
2 Global Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
3 Global Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
4 Global Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
5 Global Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
6 Global Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
7 Global Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
8 Global Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
9 Global Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
10 Global Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
11 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
12 Global Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
Global Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
13 Global Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
14 Global Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
15 Global Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
16 Global Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
17 Global Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
18 Global Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
19 Global Brain and Neuroimaging Devices Market Outlook, By Parkinson’s Disease (2021-2030) ($MN)
20 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
21 Global Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
22 Global Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
23 Global Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
24 Global Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
25 Global Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
26 Global Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
27 Global Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
28 Global Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
29 Global Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
30 North America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
31 North America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
32 North America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
33 North America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
34 North America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
35 North America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
36 North America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
37 North America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
38 North America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
39 North America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
40 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
41 North America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
42 North America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
43 North America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
44 North America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
45 North America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
46 North America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
47 North America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
48 North America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
49 North America Brain and Neuroimaging Devices Market Outlook, By Parkinson’s Disease (2021-2030) ($MN)
50 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
51 North America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
52 North America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
53 North America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
54 North America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
55 North America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
56 North America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
57 North America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
58 North America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
59 North America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
60 Europe Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
61 Europe Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
62 Europe Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
63 Europe Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
64 Europe Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
65 Europe Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
66 Europe Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
67 Europe Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
68 Europe Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
69 Europe Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
70 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
71 Europe Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
72 Europe Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
73 Europe Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
74 Europe Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
75 Europe Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
76 Europe Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
77 Europe Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
78 Europe Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
79 Europe Brain and Neuroimaging Devices Market Outlook, By Parkinson’s Disease (2021-2030) ($MN)
80 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
81 Europe Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
82 Europe Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
83 Europe Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
84 Europe Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
85 Europe Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
86 Europe Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
87 Europe Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
88 Europe Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
89 Europe Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
90 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
91 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
92 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
93 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
94 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
95 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
96 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
97 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
98 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
99 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
100 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
101 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
102 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
103 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
104 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
105 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
106 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
107 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
108 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
109 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Parkinson’s Disease (2021-2030) ($MN)
110 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
111 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
112 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
113 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
114 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
115 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
116 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
117 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
118 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
119 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
120 South America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
121 South America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
122 South America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
123 South America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
124 South America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
125 South America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
126 South America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
127 South America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
128 South America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
129 South America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
130 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
131 South America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
132 South America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
133 South America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
134 South America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
135 South America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
136 South America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
137 South America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
138 South America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
139 South America Brain and Neuroimaging Devices Market Outlook, By Parkinson’s Disease (2021-2030) ($MN)
140 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
141 South America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
142 South America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
143 South America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
144 South America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
145 South America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
146 South America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
147 South America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
148 South America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
149 South America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
150 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
151 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
152 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
153 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
154 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
155 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
156 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
157 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
158 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
159 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
160 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
161 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
162 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
163 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
164 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
165 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
166 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
167 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
168 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
169 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Parkinson’s Disease (2021-2030) ($MN)
170 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
171 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
172 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
173 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
174 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
175 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
176 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
177 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
178 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
179 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
List of Figures
List of Figures
Figure 1 Global Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 2 North America Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 3 US Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 4 Canada Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 6 Europe Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 7 Germany Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 8 UK Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 9 Italy Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 10 France Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 11 Spain Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 14 Japan Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 15 China Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 16 India Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 17 Australia Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 21 South America Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 24 Chile Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 28 UAE Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Brain and Neuroimaging Devices Market Outlook (2021-2030) ($MN)
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
